Clinical trials
Insulin Resistance trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
85 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2011 | 6 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 7 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 8 |
| 2024 | 8 |
| 2025 | 8 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 37 |
| Unknown status | 26 |
| Recruiting | 10 |
| Active, not recruiting | 6 |
| Not yet recruiting | 5 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese Medical Association | 4 |
| Peking Union Medical College Hospital | 4 |
| Eli Lilly and Company | 3 |
| Gan & Lee Pharmaceuticals. | 3 |
| Peking University Third Hospital | 3 |
| Sun Yat-sen University | 3 |
| Central South University | 2 |
| First Affiliated Hospital Xi'an Jiaotong University | 2 |
| Fudan University | 2 |
| Peking University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insulin Resistance | 85 |
| Diabetes Mellitus, Type 2 | 23 |
| Diabetes Mellitus | 18 |
| Polycystic Ovary Syndrome | 13 |
| Obesity | 9 |
| Metabolic Diseases | 6 |
| Hyperglycemia | 4 |
| Metabolic Syndrome | 4 |
| Prediabetic State | 4 |
| Critical Illness | 3 |
Trials
Showing 76 to 85 of 85. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.